CRACC/SLAMF7 Antibody (OTI1F1) [PerCP]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-72107PCP
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Flow Cytometry, Immunohistochemistry, Immunohistochemistry-Paraffin, Western Blot
Label
PerCP (Excitation = 490 nm, Emission = 675 nm)
Antibody Source
Monoclonal Mouse IgG1 Clone # OTI1F1
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Full length human recombinant protein of human SLAMF7 (NP_067004) produced in HEK293T cell.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for CRACC/SLAMF7 Antibody (OTI1F1) [PerCP]
Application
Recommended Usage
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry-Paraffin
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: CRACC/SLAMF7
Alternate Names
CD319, SLAMF7
Gene Symbol
SLAMF7
Additional CRACC/SLAMF7 Products
Product Documents for CRACC/SLAMF7 Antibody (OTI1F1) [PerCP]
Product Specific Notices for CRACC/SLAMF7 Antibody (OTI1F1) [PerCP]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...